In addition to a functional description of e-cigs, the project developed methods to analyze the pharmaceutical products (e-liquids and aerosol) consumed through e-cigs. It reviewed truth in advertising for commercially available products, assessed adulterations to the products, and evaluated potential biomarkers. Overall, this study provides greater understanding in the court systems nationwide as to the nature of drug usage, abuse, and overdose cases in which e-cigs were used to deliver an illicit drug. Given that one role of the forensic toxicologist is to define and characterize drug usage trends, the current study posed an important, relevant, and critically timed analysis to address this identified threat to public health and criminal justice. This research supports the analytical efforts in controlled substances unit and will support the findings and opinions of scientists, medical examiners, death investigators, and forensic toxicologists as they present analytical results. In addition to providing critical information at an important time in the emergence of e-cig products, this study supports the efforts by regulatory agencies to understand the e-cigarette industry. The dissemination, products, and accomplishments of this project are noted, and nine manuscripts produced from the study are cited. 21 figures and 2 tables
Downloads
Similar Publications
- IS2aR, a Computational Tool to Transform Voxelized Reference Phantoms into Patient-specific Whole-body Virtual CTs for Peripheral Dose Estimation
- High-throughput LC-PDA Method for Determination of Δ9-THC and Related Cannabinoids in Cannabis Sativa
- Trends for Background Checks for Firearm Transfers, 1999–2018: The First 20 Years of the Permanent Brady Act Period